The AIM-HI Accelerator Fund is an independent 501(C)(3) non-profit organization, established in 2019 with an initial grant from the National Foundation for Cancer Research, with the purpose to accelerate the translation of cancer drug discoveries by investing in seed-stage companies. Its Women’s Venture Competition is a first-of-its-kind initiative combining extensive opportunities for coaching, networking and financial resources exclusively to female-created and managed oncology start-ups.

Selected semi-finalists are offered access to intensive accelerator boot-camp programming by one of the world’s most renowned women entrepreneur accelerator and business training service providers, Springboard Enterprises, and—subject to due diligence and negotiation—the winning business will receive $300,000 in AIM-HI investment. 

NFCR is proud to be a partner organization for this event, helping to support and amplify the contributions of women in the field of oncology.

Help us to support oncology start-ups with a DONATION toward early seed money! Your donations will double the impact we can make together to move forward on the path to clinical trails that will eventually save lives!

2020 Finalists

Stacy Blain, Ph.D.

Founder & CSO, Concarlo Holdings

Manijeh Goldberg, Ph.D.

CEO, Privo Technologies

Partners & Sponsors